Background: Anti-PD-1/PD-L1 therapeutics have been widely used in the clinic in various tumors, including advanced esophageal cancer, showing remarkable treatment efficacy. Factors determining the response to anti-PD-1/PD-L1 therapeutics are numerous, including the tumor microenvironment, such as CD8+ T cells and expression of PD-1/PD-L1. Our study aimed to explore the effect of chemoimmunotherapy on the expression of CD8+ T cells, TIM-3, and FOXP3+ in tumor, paratumor tissues, and the expression of PD-L1, IDO, in tumor, paratumor tissues, and lymph nodes, and analyze the correlation among these markers.
Methods: A total of 18 patients were allocated into two treatment groups: a treatment group and a concurrent control group. A total of 38 tissue samples, 114 slides (tumor, paratumor, and lymph node) were collected in the treatment group, and 37 tissue samples, 111 slides (tumor, paratumor, and lymph node) were collected in the concurrent control group.
Results: The expression of PD-L1, CD8+, FOXP3+, TIM-3, and IDO in tumors, paratumor tissues, but not lymph nodes, was significantly affected by chemoimmunotherapy. Compared with patients without chemoimmunotherapy, the expression of CD8+ T cells, IDO, and PD-L1 was significantly decreased in tumor and paratumor tissues after chemoimmunotherapy, while FOXP3+ expression was significantly decreased only in tumor tissues, and TIM-3 expression was significantly decreased only in paratumor tissues. Moreover, the correlation between these markers was also completely altered after chemoimmunotherapy. In addition, N staging was associated with high expression of CD8 in advanced esophageal squamous cell carcinoma in the concurrent control group.
Conclusion: This study provides new insight into the effects of CI treatment on isolated CD8+ T cell infiltration, PD-L1, IDO, FOXP3+ and TIM-3 expression as well as their cross-talk in different tissues enabling a better understanding of the impact of CI treatment on the immune microenvironment.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9715848 | PMC |
http://dx.doi.org/10.1111/1759-7714.14683 | DOI Listing |
J Gastroenterol
January 2025
Department of Endocrinology and Metabolism, Zhongshan Hospital, Fudan University, 180 Fenglin Road, Shanghai, 200032, People's Republic of China.
Exp Mol Med
January 2025
Division of Epigenetics, DKFZ-ZMBH Alliance, German Cancer Research Center, 69120, Heidelberg, Germany.
Bladder cancer poses significant clinical challenges due to its high metastatic potential and poor prognosis, especially when it progresses to muscle-invasive stages. Here, we show that the mA reader YTHDC1 is downregulated in muscle-invasive bladder cancer and is negatively correlated with the expression of epithelial‒mesenchymal transition genes. The functional inhibition or depletion of YTHDC1 increased the migration and invasion of urothelial cells.
View Article and Find Full Text PDFAdv Sci (Weinh)
December 2024
School of Basic Medical Sciences and Biopharmaceutical Research Institute, Anhui Medical University, 81 Meishan Road, Hefei, 230032, China.
Emerging evidence suggests that the sterile alpha-motif (SAM) and histidine-aspartate (HD) domain-containing protein 1 (SAMHD1) is implicated in various cancers, including hepatocellular carcinoma (HCC). However, its precise role in tumor cells and the underlying mechanisms remain unclear. This study aimed to investigate the expression patterns, prognostic values, and functional role of SAMHD1 in HCC progression.
View Article and Find Full Text PDFInt J Gen Med
December 2024
Department of Respiratory Oncology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, 230031, People's Republic of China.
Background: Non-smoking women with lung adenocarcinoma(NSWLA) is a significant health problem globally; the carcinogenesis and prognostic signature remain poorly understood. Circular RNAs (circRNAs) are gradually implicated in cancer formation through sponging miRNAs to regulate mRNAs.
Methods: Tumor and paracancerous specimens from non-smoking women after lung adenocarcinoma surgery were collected for high-throughput sequencing of circRNA.
Oncol Lett
February 2025
Department of Oncological Surgery, People's Hospital of Zhongshan City, Zhongshan, Guangdong 528400, P.R. China.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!